A study to evaluate the clinical and microbial efficacy and safety of 1.0% AzaSite [azithromycin] compared to vehicle in the treatment of bacterial conjunctivitis
Phase of Trial: Phase III
Latest Information Update: 20 Nov 2013
At a glance
- Drugs Azithromycin (Primary)
- Indications Bacterial infections; Infectious conjunctivitis
- Focus Therapeutic Use
- 20 Sep 2011 Company added as trial sponso as reported by ClinicalTrials.gov.
- 30 Sep 2005 New trial record.